Posts

Showing posts from July, 2024

EU Pharma Reform in Focus: Implications for Innovation and Access

KISUNLA: Otro avance para los pacientes con enfermedad de Alzheimer

KISUNLA: Another breakthrough for Alzheimer’s Disease patients